Saturday 17 October 2026 Export CC’s income statement to Excel — free account

The Chemours Company

The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue fell 1.49%, EPS grew 28.7%, free cash flow grew 128.0% and total debt fell 6.47%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

12.66 0.25 −1.94%

Follow CC

Alert me

Market cap: $1.9B
P/E: 0.0×
Fwd P/E: 16.9×
Dividend yield: 2.76%
F-score: 4/9
Altman Z: 1.35
Beneish M: −2.91
Dividend safety: 0/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.49

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	7	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 1.43%

Capital & Financial Ratios $m

Market Cap 1,940.00

Revenue 5,797.00

Net Income (305.00)

Free Cash Flow 218.00

Net Debt 3,201.00

Current Ratio 1.66

Debt/Equity (80.67)

P/E ratio 0.00

Fwd P/E 16.90

P/S ratio 0.33

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth 0.08%

Next Y EPS Growth 98.03%

Next Y revenue growth 1.88%

Next 5Y EPS Growth 34.00%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 10.91%

10-year low 10-year high

EV/Sales against its own 10 years 3.61%

10-year low 10-year high

EV/FCF against its own 10 years 48.51%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate 0.35

Annual Dividend Yield 2.76%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	0.35	0.09 0.09 0.09
2025	0.51	0.25 0.09 0.09 0.09
2024	1.00	0.25 0.25 0.25 0.25
2023	1.00	0.25 0.25 0.25 0.25
2022	1.00	0.25 0.25 0.25 0.25
2021	1.00	0.25 0.25 0.25 0.25
2020	1.00	0.25 0.25 0.25 0.25
2019	1.00	0.25 0.25 0.25 0.25
2018	0.84	0.17 0.17 0.25 0.25
2017	0.12	0.03 0.03 0.03 0.03
2016	0.12	0.03 0.03 0.03 0.03

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	1,807	713	672	671
Receivables	610	770	679	907
Inventory	1,352	1,463	1,569	1,452
Other	—	—	1	1
	3,835	3,017	3,001	3,094

	2023	2024	2025	Q'26
Payables	1,159	1,156	954	937
ST’ Debt	51	54	42	34
Other	218	214	184	207
	2,486	1,820	1,686	1,861

Compound Annual Growth %

	10y	5y	3y
Sales	0.16%	3.17%	(5.26%)
Cash Flow	3.79%	(20.03%)	(29.55%)
Earnings	0.00%	0.00%	0.00%
Book Value	6.80%	(20.99%)	(39.02%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	1,381	1,591	—	—	—
’25	1,368	1,615	1,495	1,330	5,808
’24	1,362	1,554	1,508	1,358	5,782
’23	1,536	1,643	1,487	1,412	6,078
’22	1,764	1,915	1,777	1,375	6,831
’21	1,436	1,655	1,680	1,574	6,345
’20	1,305	1,093	1,233	1,338	4,969

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(44)	158	—	—	—
’25	(112)	93	146	137	264
’24	(290)	(620)	139	138	(633)
’23	(124)	67	131	482	556
’22	2	291	301	161	755
’21	39	256	311	208	814
’20	44	111	299	353	807

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(93)	114	—	—	—
’25	(196)	50	112	85	51
’24	(389)	(693)	63	26	(993)
’23	(215)	9	183	209	186
’22	(104)	229	229	127	481
’21	(21)	189	244	125	537
’20	(62)	50	252	300	540

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.19)	(1.81)	—	—	—
’25	(0.03)	(2.54)	0.40	(0.31)	(2.56)
’24	0.34	0.46	(0.18)	(0.09)	0.57
’23	0.96	(2.52)	0.08	(0.21)	(1.60)
’22	1.43	1.26	1.52	(0.64)	3.65
’21	0.57	0.39	1.27	1.40	3.60
’20	0.61	0.15	0.46	0.11	1.32

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	3.06	20.76	25.17	11.71	7.02	23.30	22.56	22.88	15.10	9.13	Analyst estimates 2026–2028 Powerpack
	High	27.29	58.08	54.62	41.60	27.87	38.87	44.95	39.05	32.70	20.12
People
People	Employees	7,000	7,000	7,000	7,000	6,500	6,400	6,600	6,200	6,000	5,700
	Revenue/emp, $m	0.77	0.88	0.95	0.79	0.76	0.99	1.04	0.98	0.96	1.02
Income, $m
Income, $m	Revenue	5,400	6,183	6,638	5,526	4,969	6,345	6,831	6,078	5,782	5,808
	Gross margin, %	20.43	28.22	29.69	19.24	21.47	21.77	23.66	21.42	19.75	15.53
	EBT	(11)	912	1,155	(124)	179	676	741	(318)	106	(277)
	EBT margin, %	(0.20)	14.75	17.40	(2.24)	3.60	10.65	10.85	(5.23)	1.83	(4.77)
	Net income	7	747	996	(52)	219	608	578	(252)	69	(386)
	Depreciation	300	286	295	320	329	326	300	318	360	351
Per share, $
Per share, $	Revenue	29.73	33.45	37.51	33.53	30.17	38.47	43.97	40.82	38.68	38.66
	Earnings	0.04	4.04	5.62	(0.32)	1.33	3.69	3.72	(1.60)	0.46	(2.57)
	Cash flow	3.27	3.46	6.44	3.94	4.90	4.94	4.86	3.73	(4.23)	1.76
	Capex	(1.86)	(2.22)	(2.81)	(2.92)	(1.62)	(1.68)	(1.76)	(2.48)	(2.41)	(1.42)
	Free cash flow	1.41	1.24	3.63	1.03	3.28	3.26	3.10	1.25	(6.64)	0.34
	Book value	0.57	4.68	5.76	4.22	4.95	6.56	7.13	4.96	3.83	1.67
	Shares, m	182	185	177	165	165	165	155	149	149	150
Valuation, ×
Valuation, ×	P/E	530.50	12.81	5.04	0.00	18.50	9.05	8.41	0.00	30.65	0.00
	P/S	0.71	1.55	0.75	0.54	0.82	0.87	0.70	0.78	0.44	0.31
	P/B	37.06	11.06	4.90	4.29	5.01	5.12	4.30	6.40	4.42	7.06
	EV/Sales	1.20	1.96	1.17	1.12	1.41	1.23	1.07	1.15	1.03	0.90
	EV/FCF	25.38	52.93	12.10	36.68	12.97	14.59	15.15	37.44	(5.97)	102.75
Cash, $m
Cash, $m	Operating cash flow	594	640	1,140	650	807	814	755	556	(633)	264
	Capex	(338)	(411)	(498)	(481)	(267)	(277)	(274)	(370)	(360)	(213)
	Free cash flow	256	229	642	169	540	537	481	186	(993)	51
Balance, $m
Balance, $m	Working capital	782	1,845	1,584	1,236	1,191	1,487	1,323	1,349	1,197	1,315
	Total debt	3,544	4,112	3,972	4,160	4,026	3,749	3,633	4,038	4,113	4,141
	Net debt	2,642	2,556	2,771	3,217	2,921	2,298	2,531	2,231	3,400	3,469
	Shareholders’ equity	104	865	1,020	695	815	1,082	1,107	739	572	251
Returns, %
Returns, %	ROA	0.11	11.17	13.58	(0.71)	3.05	8.31	7.61	(3.18)	0.88	(5.18)
	ROIC	(2.14)	17.92	19.50	5.56	6.14	12.50	13.26	(5.16)	5.02	(1.08)
	ROE	5.98	153.97	105.57	(6.06)	29.01	64.10	52.81	(27.41)	10.53	(93.80)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
FUL H. B. Fuller Company	$2.8B	14.1×	16.8×	+5.17% (above 0%: growing)	+18.19% (above 0%: growing)	−58.41% (below 0%: shrinking)	33.22%	12.07%	Compare
HWKN Hawkins, Inc.	$2.8B	33.8×	36.3×	+7.64% (above 0%: growing)	−3.55% (below 0%: shrinking)	+30.29% (above 0%: growing)	23.44%	12.25%	Compare
KWR Quaker Houghton	$2.7B	27.9×	25.2×	+10.17% (above 0%: growing)	n/m	−43.19% (below 0%: shrinking)	35.53%	7.62%	Compare
WDFC WD-40 Company	$2.7B	30.3×	34.0×	+24.35% (above 0%: growing)	+45.45% (above 0%: growing)	−13.28% (below 0%: shrinking)	56.59%	20.67%	Compare
NGVT Ingevity Corporation	$2.4B	45.3×	18.5×	−5.25% (below 0%: shrinking)	n/m	−136.08% (below 0%: shrinking)	44.25%	19.13%	Compare
IOSP Innospec Inc.	$2.4B	19.7×	16.3×	+11.76% (above 0%: growing)	+32.98% (above 0%: growing)	−63.16% (below 0%: shrinking)	28.14%	8.08%	Compare
MTX Minerals Technologies Inc.	$2.0B	— (loss-making)	12.4×	+3.69% (above 0%: growing)	n/m	+5.92% (above 0%: growing)	24.40%	(40.17%)	Compare
CC The Chemours Company	$1.9B	— (loss-making)	16.9×	−1.49% (below 0%: shrinking)	n/m	+128.00% (above 0%: growing)	17.98%	(13.39%)
SCL Stepan Company	$1.4B	— (loss-making)	2,564×	+15.04% (above 0%: growing)	+100.00% (above 0%: growing)	−4.42% (below 0%: shrinking)	14.61%	5.44%	Compare
Median of peers	$2.6B	29.1×	21.9×	+8.90%	+32.98%	−28.23%	30.68%	10.08%

All 60 Specialty Chemicals stocks →